Inogen (INGN)
(Delayed Data from NSDQ)
$8.07 USD
-0.45 (-5.28%)
Updated Jun 4, 2024 04:00 PM ET
After-Market: $8.08 +0.01 (0.12%) 7:58 PM ET
2-Buy of 5 2
C Value A Growth B Momentum A VGM
Brokerage Reports
Inogen, Inc [INGN]
Reports for Purchase
Showing records 1 - 20 ( 284 total )
Company: Inogen, Inc
Industry: Medical - Instruments
Provider: Zacks Investment Research
Analyst: Research Department
Company: Inogen, Inc
Industry: Medical - Instruments
Provider: Zacks Investment Research
Analyst: Research Department
Company: Inogen, Inc
Industry: Medical - Instruments
Provider: Zacks Investment Research
Analyst: Research Department
Company: Inogen, Inc
Industry: Medical - Instruments
Provider: Zacks Investment Research
Analyst: Research Department
Company: Inogen, Inc
Industry: Medical - Instruments
Provider: Zacks Investment Research
Analyst: Research Department
Company: Inogen, Inc
Industry: Medical - Instruments
Provider: Zacks Investment Research
Analyst: Research Department
Company: Inogen, Inc
Industry: Medical - Instruments
Provider: Zacks Investment Research
Analyst: Research Department
Company: Inogen, Inc
Industry: Medical - Instruments
Provider: Zacks Investment Research
Analyst: Research Department
Company: Inogen, Inc
Industry: Medical - Instruments
Provider: Zacks Investment Research
Analyst: Research Department
Company: Inogen, Inc
Industry: Medical - Instruments
Optimized Entry and Exit Levels for INGN 112123
Provider: Stock Traders Daily
Analyst: Research Department
Company: Inogen, Inc
Industry: Medical - Instruments
Company: Inogen, Inc
Industry: Medical - Instruments
Provider: Zacks Investment Research
Analyst: Research Department
Company: Inogen, Inc
Industry: Medical - Instruments
Company: Inogen, Inc
Industry: Medical - Instruments
Provider: Zacks Investment Research
Analyst: Research Department
Company: Inogen, Inc
Industry: Medical - Instruments
Company: Inogen, Inc
Industry: Medical - Instruments
Provider: Zacks Investment Research
Analyst: Research Department
Company: Inogen, Inc
Industry: Medical - Instruments
Medical Technology: Suspending Coverage of 21 Companies
Provider: KeyBanc Capital Markets
Analyst: Research Department